Filing Details

Accession Number:
0001127602-11-030449
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-23 16:03:24
Reporting Period:
2011-11-21
Filing Date:
2011-11-23
Accepted Time:
2011-11-23 16:03:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
946840 Viropharma Inc VPHM Pharmaceutical Preparations (2834) 232789550
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187159 Vincent Milano 730 Stockton Drive
Exton PA 19341
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-21 15,000 $2.09 91,208 No 4 M Direct
Common Stock Disposition 2011-11-21 15,000 $22.53 76,208 No 4 S Direct
Common Stock Acquisiton 2011-11-21 19,996 $3.93 96,204 No 4 M Direct
Common Stock Disposition 2011-11-21 19,996 $22.53 76,208 No 4 S Direct
Common Stock Acquisiton 2011-11-21 41,691 $3.55 117,899 No 4 M Direct
Common Stock Disposition 2011-11-21 41,691 $22.53 76,208 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (Right to Buy) Disposition 2011-11-21 15,000 $0.00 15,000 $2.09
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2011-11-21 19,996 $0.00 19,996 $3.93
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2011-11-21 41,691 $0.00 41,691 $3.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,000 2004-07-22 2013-07-22 No 4 M Direct
4 2003-04-16 2012-04-16 No 4 M Direct
58,309 2005-01-15 2014-01-15 No 4 M Direct
Footnotes
  1. The options vest in four equal annual installments beginning on the anniversary date from time of grant.
  2. Includes 903 shares of common stock issued pursuant to the ViroPharma Employee Stock Purchase Plan on December 31, 2011.
  3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2011.
  4. Includes 915 shares of common stock issued pursuant to the ViroPharma Employee Stock Purchase Plan on June 30, 2011.